DE1518764C3 - In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester - Google Patents

In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester

Info

Publication number
DE1518764C3
DE1518764C3 DE1518764A DEE0029512A DE1518764C3 DE 1518764 C3 DE1518764 C3 DE 1518764C3 DE 1518764 A DE1518764 A DE 1518764A DE E0029512 A DEE0029512 A DE E0029512A DE 1518764 C3 DE1518764 C3 DE 1518764C3
Authority
DE
Germany
Prior art keywords
phenyl
benzodiazepine
oxo
carboxylic acid
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1518764A
Other languages
German (de)
English (en)
Other versions
DE1518764B2 (de
DE1518764A1 (de
Inventor
Josef L'hay-Les-Roses Seine Schmitt (Frankreich)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Cm Industries Sa Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm Industries Sa Paris filed Critical Cm Industries Sa Paris
Publication of DE1518764A1 publication Critical patent/DE1518764A1/de
Publication of DE1518764B2 publication Critical patent/DE1518764B2/de
Application granted granted Critical
Publication of DE1518764C3 publication Critical patent/DE1518764C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Perforating, Stamping-Out Or Severing By Means Other Than Cutting (AREA)
  • Devices For Post-Treatments, Processing, Supply, Discharge, And Other Processes (AREA)
DE1518764A 1964-06-15 1965-06-14 In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester Expired DE1518764C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR978360A FR1497456A (fr) 1964-06-15 1964-06-15 Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et prépaation de ces divers corps
FR12886A FR91403E (fr) 1964-06-15 1965-04-12 Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et préparation de ces divers corps

Publications (3)

Publication Number Publication Date
DE1518764A1 DE1518764A1 (de) 1971-11-04
DE1518764B2 DE1518764B2 (de) 1979-06-21
DE1518764C3 true DE1518764C3 (de) 1980-02-21

Family

ID=26163072

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1518764A Expired DE1518764C3 (de) 1964-06-15 1965-06-14 In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester
DE1795832A Expired DE1795832C3 (de) 1964-06-15 1965-06-14 O-Aminoarylketimine und Verfahren zu ihrer Herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1795832A Expired DE1795832C3 (de) 1964-06-15 1965-06-14 O-Aminoarylketimine und Verfahren zu ihrer Herstellung

Country Status (17)

Country Link
US (1) US3516988A (enExample)
AT (2) AT268285B (enExample)
BE (1) BE665401A (enExample)
BR (1) BR6570433D0 (enExample)
CA (2) CA958707A (enExample)
CH (2) CH485741A (enExample)
DE (2) DE1518764C3 (enExample)
DK (3) DK138493B (enExample)
FI (2) FI47986C (enExample)
FR (3) FR1497456A (enExample)
GB (3) GB1117061A (enExample)
IL (2) IL23712A (enExample)
MY (3) MY7100181A (enExample)
NL (2) NL155545B (enExample)
NO (1) NO120115B (enExample)
SE (2) SE336341B (enExample)
YU (3) YU32996B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL33961A (en) * 1969-03-13 1973-03-30 Sparamedica Ag Benzodiazepine aminoalkyl carboxylates,their preparation and pharmaceutical compositions containing them
FR2012061A1 (en) * 1969-06-30 1970-03-13 Sandoz Sa Quinazolinone derivs - with antiphlogistic props
GB1538164A (en) * 1976-05-05 1979-01-10 Clin Midy Benzodiazepine derivatives
FR2470116A1 (fr) * 1979-11-27 1981-05-29 Synthelabo Derives benzylideniques, leur preparation et leur application en therapeutique
JPS6019753A (ja) * 1983-07-13 1985-01-31 Shionogi & Co Ltd オルト−（モノ置換アミノ）フエニルイミン類およびその製造法
JPS6038380A (ja) * 1983-08-11 1985-02-27 Shionogi & Co Ltd １−ピペリジニル−１，４−ベンゾジアゼピン類の改良合成法
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
JP5127096B2 (ja) * 1999-04-30 2013-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用
CA2446696A1 (fr) * 2001-06-07 2002-12-12 Neuro3D Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
US12252457B2 (en) 2018-05-22 2025-03-18 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3801512A4 (en) 2018-05-29 2022-01-19 President and Fellows of Harvard College COMPOSITIONS AND METHODS TO REDUCE TACTILE DYSFUNCTION, ANXIETY AND SOCIAL DISABILITIES
US12077512B2 (en) 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3410844A (en) * 1966-03-14 1968-11-12 American Home Prod 2, 3, 4, 5-tetrahydro-2-oxo-1h-1, 4-benzodiazepine-3-carboxylic acid, esters and related compounds

Also Published As

Publication number Publication date
DK138493B (da) 1978-09-18
YU100565A (en) 1975-08-31
DE1795832B2 (de) 1980-07-17
DK129126B (da) 1974-08-26
YU45468A (en) 1980-10-31
MY7100180A (en) 1971-12-31
CA958707A (en) 1974-12-03
NL7500364A (en) 1975-04-29
FI47986B (enExample) 1974-01-31
GB1117062A (en) 1968-06-12
MY7100181A (en) 1971-12-31
DE1518764B2 (de) 1979-06-21
BR6570433D0 (pt) 1973-08-14
IL32140A (en) 1969-07-30
FR4206M (enExample) 1966-07-11
SE386891B (sv) 1976-08-23
IL23712A (en) 1969-07-30
FI47986C (fi) 1974-05-10
YU32996B (en) 1976-03-31
GB1117061A (en) 1968-06-12
DK125856B (da) 1973-05-14
FR1497456A (fr) 1967-10-13
GB1117063A (en) 1968-06-12
NL155545B (nl) 1978-01-16
SE336341B (enExample) 1971-07-05
DE1795445B2 (de) 1976-02-26
CA958708B (en)
DK129126C (enExample) 1975-01-06
NL6507637A (enExample) 1965-12-16
CH485741A (fr) 1970-02-15
CA958708A (en) 1974-12-03
NO120115B (enExample) 1970-08-31
AT268285B (de) 1969-02-10
DE1518764A1 (de) 1971-11-04
CA958707B (en)
AT284084B (de) 1970-08-25
FI51586C (fi) 1977-02-10
MY7100179A (en) 1971-12-31
US3516988A (en) 1970-06-23
FI51586B (enExample) 1976-11-01
NL155828B (nl) 1978-02-15
CH479552A (fr) 1969-10-15
DE1795832C3 (de) 1981-07-02
DE1795445A1 (de) 1973-01-11
DE1795832A1 (de) 1976-04-22
FR91403E (fr) 1968-06-07
DK138493C (enExample) 1979-02-26
YU35570B (en) 1981-04-30
BE665401A (enExample) 1965-12-14

Similar Documents

Publication Publication Date Title
DE1518764C3 (de) In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester
AT391700B (de) Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate
EP0071738B1 (de) Neue Theophyllinderivate und Verfahren zu deren Herstellung
DE1770171C3 (de) 2,2-Dimethyl-7-alkyl-4-(4-pyridyl)-2H-chromen-5-ole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2842263A1 (de) Herstellung chromogener pyridinverbindungen
DE2253914C3 (de) Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel
DE1961595A1 (de) Pyridincarbonylderivate des 7-[Omega(N-Alkylamino)-hydroxyalkyl]-theophyllins und Verfahren zu deren Herstellung
DE2456098C3 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0019157A1 (de) 5,6-Dihydro-11-alkylen-morphantridin-6-one und Verfahren zu ihrer Herstellung
DE1545782A1 (de) Neue Noralkaloide und Verfahren zu deren Herstellung
DE2213076A1 (de) Isoxazolo(3,4-b)pyridin-5-carbonsäuren, deren Ester und Salze
DE744280C (de) Verfahren zur Herstellung von Pyrimidinabkoemmlingen
DE2264638C2 (de) 5'-Acetyl-2,2'-cyclocytidin-Derivate
DE1768787C3 (de) (o-Carboxy-phenyl)-acetamidine, Verfahren zu deren Herstellung und (o-CarboxyphenyO-acetamidine enthaltende Präparate
DE520078C (de) Verfahren zur Darstellung von Doppelverbindungen quaternaerer Salze des 3, 6-Diamino-10-alkylacridiniums
DE1595870A1 (de) Verfahren zur Herstellung von 3-(o-Methoxyphenoxy)-1,2-propandiolnicotinaten und deren Salzen
DE2804520A1 (de) Verfahren zur herstellung von benzylpyrimidinen
DE1620195C (de) Optisch aktive und racemische Berbin derivate und em Verfahren zu ihrer Her stellung Ausscheidung aus 1620172
DE1965894C2 (de) 2-Hydrazino-5-phenyl-3H-1,4-benzodiazepinderivate und Verfahren zu ihrer Herstellung
AT338288B (de) Verfahren zur herstellung neuer 7,7'-verbruckter bis-theophylline
DE1620172C (de) Optisch aktives oder racemisches 2,3-Dimethoxy-10-aminoberbin, dessen Salze und Verfahren zur Herstellung dieser Verbindung
CH514595A (de) Verfahren zur Herstellung von Verbindungen mit beruhigender Wirkung
DE2329809A1 (de) Neue aminoderivate von pyrazolopyridincarbonsaeuren
DE2518516B2 (de) 2-(3,4,5-trimethoxybenzyl)-3,4-dimethyl- pyridin
CH631175A5 (en) Processes for preparing a novel alkaloid of the vincamine type and salts thereof.

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI, 75008 PARIS, FR